Home
>
Stock Market
>
>
Sun Pharmaceuticals Industries Ltd

Sun Pharmaceuticals Industries Ltd share price and stock overview

Sun Pharmaceuticals Industries Ltd (NSE: SUNPHARMA, BSE: 524715) operates in the Pharmaceuticals - Indian - Bulk Drugs & Formln sector. The stock has an ISIN of INE044A01036 and a face value of Rs 1. As of 26 October 2026, it trades at Rs (1,748.00) with a market capitalisation of Rs 418204.09 crore. Figures are live and subject to change.

Sun Pharmaceuticals Industries Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

NSE BSE

1,748.00 -10.00 (-0.57%) downArrowC

As on: 26-Oct-2026 , 01:27 AM

Market Cap(₹Cr) 418204.09

Book Value(₹Cr) 93.2373503

BSE Code : 524715 NSE Symbol : SUNPHARMA EPS(TTM) : 13.27 ISIN Demat : INE044A01036 P/E(TTM) : 131.35 Face Value(₹) : 1 Div & Yield % : 0.92

Today Market

Stock Performance

Today Market

Today's High

73,766.51

Todday's Low

72,452.37

Open at

73,665.64

Previous Close

73,249.39

Volumes

Avg Price

-125.56

Historical Performance

News

14 Oct 26

Sun Pharma to review quarterly results at a board meeting on October 30, 2026

Sun Pharmaceutical Industries Limited will hold a board meeting on Friday, October 30, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, according to a regulatory filing.

14 Oct 26

Sun Pharma confirms certificate submission to SEBI via Registrar, MUFG Intime India

Sun Pharmaceutical Industries Limited submitted a confirmation certificate dated October 3, 2026, received from MUFG Intime India Private Limited, its Registrar & Share Transfer Agent, pertaining to the quarter ended September 30, 2026, as per Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.

13 Oct 26

Sun Pharma's ratings reaffirmed by CRISIL, India Ratings, and CARE, covering INR 30,000 crore

Sun Pharmaceutical Industries Ltd announced today that CRISIL Ratings has reaffirmed its ratings on the company, including the long-term rating of "CRISIL AAA/Stable" and the short-term rating of "CRISIL A1+," while simultaneously withdrawing the ratings as they are no longer required by the rated entity; India Ratings & Research (Ind-Ra) has also reaffirmed its ratings, assigning a long-term rating of "IND AAA (Stable)" and a short-term rating of "IND A1+"; furthermore, CARE Ratings has reaffirmed its ratings, maintaining a long-term rating of "CRISIL AAA (Stable)" and a short-term rating of "CRISIL A1+," with a standalone credit watch positive; these ratings cover bank loan facilities aggregating to INR 27,000 crore, commercial paper of INR 2,000 crore, and preference shares amounting to INR 1,000 crore, with the reaffirmations reflecting Sun Pharma’s strong financial risk profile and market position, and the withdrawals by CRISIL are solely due to the company’s request.

07 Oct 26

Sun Pharma to seek board approval for potential Rs 15,000 crore NCD issuance

Sun Pharmaceutical Industries Limited will convene a board meeting on Monday, 12 October 2026, to consider and approve the issuance of listed, rated, unsecured, redeemable non-convertible debentures (NCDs) in one or more tranches, on a private placement basis, for an aggregate amount not exceeding Rs 15,000 crore.

Historical Prices

Share Price Chart

Historical Share Price

Date	Open Price (₹)	High Price(₹)	Low Price(₹)	Close Price(₹)	Total Volume	No of Trades	Net Turnover(₹)	NIFTY
23-10-26	1757.40	1765.40	1735.20	1748.00	1064528	58525	1858556327.60	22600.00
22-10-26	1732.00	1758.00	1719.10	1758.00	1778519	72383	3104183488.20	22687.65
21-10-26	1753.00	1755.60	1721.10	1745.10	2316342	107460	4017525109.80	22811.35
19-10-26	1758.80	1768.90	1735.30	1743.00	829445	48891	1449039755.80	22888.95
16-10-26	1762.20	1764.90	1743.50	1758.80	1522459	96247	2671661315.60	23146.15
15-10-26	1736.00	1778.00	1734.10	1764.00	1376380	60010	2429789831.30	22997.35
14-10-26	1770.10	1770.10	1725.50	1746.40	1808782	152631	3147003488.70	22622.70
13-10-26	1760.00	1770.70	1750.60	1770.70	1191057	74687	2099663478.20	22721.95
12-10-26	1764.30	1776.60	1750.00	1760.00	1141685	51884	2009895630.40	22363.35
09-10-26	1756.20	1776.80	1751.00	1760.00	1346107	57377	2375817649.70	22520.45

12 3 ...

Fundamentals

Company Valuation

Market Cap (₹cr)

418204.09

PE Ratio

131.35

PB Ratio

18.69

Dividend Yield

0.92

ROE

12.73

ROCE

14.47

Book Value (₹)

93.2373503

Face Value (₹)

Share Holding Pattern

Category of Shareholder	No of Shares	% Share Holdings	Demat Shares	Share Holders

Promoter & Group

Foreign

Foreign (Promoter & Group) - Bodies Corporate	0	0.00	0	0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign)	0	0.00	0	0
Foreign Promoter(Institutional)	0	0.00	0	0
Promoter Others	0	0.00	0	0

Sub Total

0.00

Indian

Bodies Corporate-Indian (Promoter & Group)	1017657248	42.41	1017645248	6
Government(Central / State)-Indian (Promoter & Group)	0	0.00	0	0
Directors & their Relatives-Indian (Promoter & Group)	0	0.00	0	0
Financial Institutions / Banks-Indian (Promoter & Group)	0	0.00	0	0
Individuals / Hindu Undivided Family-Indian (Promoter & Group)	245010142	10.21	245010142	5
Partnership Firms-Indian (Promoter & Group)	0	0.00	0	0
Persons Acting in Concert	0	0.00	0	0
Trusts	1276774	0.05	1276774	1
Others	0	0.00	0	0

Sub Total

1263944164

52.68

1263932164

Total ShareHolding for Promoter & Group

1263944164

52.68

1263932164

Publice Share Holding

Institution

Government(Central / State)	23383	0.00	23383	6
Clearing Members	0	0.00	0	0
Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
Financial Institutions / Banks	1212588	0.05	1212588	5
Foreign Bank	0	0.00	0	0
Foreign Bodies Corporate/OCBs/FBC	0	0.00	0	0
Foreign Collaborators	0	0.00	0	0
Foreign Institutional Investors	344498929	14.36	344490372	1080
Foreign Venture Capital Investors	0	0.00	0	0
Foreign Institution Other	0	0.00	0	0
Insurance Companies	163101946	6.80	163101946	34
Mutual Funds / UTI	312058523	13.01	312049611	51
Individuals (Non-Resident / Foreign)	0	0.00	0	0
NSDL Intransit	0	0.00	0	0
Others	57859612	2.41	57859612	60
Trusts	0	0.00	0	0
Venture Capital Funds	0	0.00	0	0

Sub total

878754981

36.62

878737512

1236

Non Institution

Bodies Corporate	55570588	2.32	55517974	2728
Clearing Members	1837947	0.08	1837947	91
Directors & their Relatives	25155	0.00	25155	3
Employees	0	0.00	0	0
Escrow Account	0	0.00	0	0
Foreign Corporate Bodies	46000	0.00	46000	1
Foreign Direct Investments	0	0.00	0	0
NRIs/Foreign Individuals/Foreign Nationals	6934809	0.29	6863457	21917
Foreign Non Institution Other	0	0.00	0	0
Hindu Undivided Families	3504628	0.15	3502460	8663
Indian Public	0	0.00	0	0
Individuals holding nominal share capital in excess of Rs. 1 lakh	55547276	2.32	55547276	33
Individuals holding nominal share capital up to Rs. 1 lakh	105351481	4.39	102702082	679318
Market Maker	0	0.00	0	0
NSDL Transit	0	0.00	0	0
Shares in transit	0	0.00	0	0
Societies	0	0.00	0	0
Trust & Foundation	1739995	0.07	1739995	52
Others	23346622	0.97	23346622	7

Sub Total

256635825

10.70

253859268

713018

Total Public Shareholding

1135390806

47.32

1132596780

714254

Total of Promoter & Public ShareHolding

2399334970

100.00

2396528944

714266

Shares held by Custodians and against which Depository Receipts have been issued

ADR	0	0.00	0	0
GDR	0	0.00	0	0
Other Custodians	0	0.00	0	0

Total Shares held by Custodians and against which Depository Receipts have been issued

0.00

Grand Total

2399334970

100.00

2396528944

714266

Financials (₹ in cr)

Consolidated Standalone

Year End	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Net Sales	58,462.04	52,578.44	48,496.85	43,885.68	38,654.49
OPM (%)	28.10	27.44	23.88	21.83	23.41
OP	16,426.36	14,429.98	11,582.21	9,579.88	9,048.14
Other Income	3,211.90	2,150.57	1,390.32	634.52	1,075.47
PBIDT	18,395.64	16,558.88	13,883.00	12,109.86	6,752.41
INTEREST	338.91	231.36	238.47	172.00	127.35
PBDT	18,056.73	16,327.52	13,644.53	11,937.86	6,625.06
PBT	13,811.40	13,074.28	10,593.57	9,236.98	-85.50
EO	-1,307.48	-677.85	-494.32	-171.45	-4,566.82
PBT after EO	15,118.88	13,752.13	11,087.89	9,408.43	4,481.32
TAXES	3,554.36	2,772.03	1,439.45	847.59	1,075.50
PAT	11,479.42	10,929.04	9,576.38	8,473.58	3,272.73
EPS	47.80	45.60	39.90	35.30	13.60
Raw Material	12.64	12.27	14.24	17.72	18.24
Power and Fuel	1.39	1.43	1.57	1.89	1.82
Employee Cost	19.53	18.97	19.44	18.90	18.89
Other Manufacturing Expenses	0.00	0.00	1.30	1.28	1.44
Selling and Administration Expenses	23.66	23.25	22.75	21.61	19.06
Miscellaneous Expenses	3.08	2.92	2.96	2.35	2.09
Revenue (Growth %)	11.19	8.42	10.51	13.53	15.39
PBIDT (Growth %)	11.09	19.27	14.64	79.34	34.49
PAT (Growth %)	5.04	14.12	13.01	158.91	12.70
PBIDT (Margin %)	31.47	31.49	28.63	27.59	17.47
PAT (Margin %)	19.64	20.79	19.75	19.31	8.47

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Share Capital	239.93	239.93	239.93	239.93	239.93	239.93
Reserves Total	22130.83	23660.36	23454.47	23508.43	24348.02	26698.54
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	22370.76	23900.29	23694.40	23748.36	24587.95	26938.47
Secured Loans	0.00	0.00	0.00	0.00	0.00	5.41
Unsecured Loans	13604.73	11947.07	11226.91	7790.82	5074.04	7352.71
Total Debt	13604.73	11947.07	11226.91	7790.82	5074.04	7358.12
Other Liabilities	600.16	799.84	1722.96	1105.45	1016.38	1342.13
Total Liabilities	36575.65	36647.20	36644.27	32644.63	30678.37	35638.72
APPLICATION OF FUNDS :
Gross Block	20680.59	19199.84	18251.74	17744.68	17194.98	15812.29
Less : Accumulated Depreciation	13067.50	11827.41	10515.00	9033.01	7482.20	6143.50
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	7613.09	7372.43	7736.74	8711.67	9712.78	9668.79
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	899.39	1084.20	766.11	852.91	828.64	1090.38
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	12951.56	12410.11	12429.97	12613.24	15548.87	15537.20
Current Assets, Loans & Advances
Inventories	4302.27	3934.13	3423.62	3989.19	3403.74	3423.42
Sundry Debtors	10166.23	11701.54	8834.16	7125.02	4245.16	6585.24
Cash and Bank Balance	436.97	911.05	338.39	421.28	534.96	360.98
Loans and Advances	1773.25	2233.98	2316.37	4708.00	1326.85	2329.44
Total Current Assets	16678.72	18780.70	14912.54	16243.49	9510.71	12699.08
Less : Current Liabilities and Provisions
Current Liabilities	5340.12	6507.51	3811.44	7533.36	7524.56	6891.41
Provisions	1143.77	723.76	609.08	809.50	2562.55	1204.66
Total Current Liabilities & Provisions	6483.89	7231.27	4420.52	8342.86	10087.11	8096.07
Net Current Assets	10194.83	11549.43	10492.02	7900.63	-576.40	4603.01
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	1277.96	2053.68	1889.79	1982.84	1389.47	1969.40
Deferred Tax Liability	538.56	886.04	895.27	950.45	1065.43	631.95
Net Deferred Tax	739.40	1167.64	994.52	1032.39	324.04	1337.45
Other Assets	4177.38	3063.39	4224.91	1533.79	4840.44	3401.89
Total Assets	36575.65	36647.20	36644.27	32644.63	30678.37	35638.72
Contingent Liabilities	1326.93	1990.94	941.73	1087.40	1031.72	3083.04

Cash Flow (₹ in cr)

Yearly Cash Flow	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Financing Activities	-4,870.85	169.31	473.95	-3,836.13	-5,230.18
Investing Activities	-2,697.04	-685.64	-265.35	-250.64	-1,345.42
Net Cash Flow	68.47	-9.25	-83.82	165.20	-74.73
Operating Activities	7,636.36	507.08	-292.42	4,251.97	6,500.87

Peers

Balance Sheet Financial Ratios Profit & Loss

Aarti Pharmalabs...

820.85

(-0.96%)

Accent Microcell...

592.50

(-3.92%)

Accretion Pharma...

182.10

(-3.80%)

Achyut Healthcar...

Advanced Enzyme ...

248.35

(-4.06%)

Akums Drugs & Ph...

669.00

(-1.65%)

Albert David Ltd

763.70

(-2.63%)

Alembic Pharmace...

760.10

(-2.71%)

Corporate Actions

Bonus Dividends Splits

Date	Corporate Action	Information
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer

DSS

Dilip S Shanghvi

Chairman / Executive Director / M D / Promoter

Executive

Functional Directors

KWG

Kirti Wardhaman Ganorkar

Executive Director & MD

Exec.

Vidhi Shanghvi

E D & Wholetime Director

Dir.

Independent Directors

Pawan Goenka

Lead Independent Non Executive Director

Ind.

Rolf Hoffmann

Independent Non Exe. Director

Ind.

Satyavati Berera

Independent Non Exe. Director

Ind.

Andreas Busch

Independent Non Exe. Director

Ind.

Other Officials

ADS

AALOK DILIP SHANGHVI

ED / WTD / CFO / Promoter

Board

AAD

ANOOP ANJANIKUMAR DESHPANDE

Company Sec. & Compli. Officer

Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Sun Pharmaceuticals Industries Ltd? −

Sun Pharmaceuticals Industries Ltd trades on NSE under SUNPHARMA and on BSE under code 524715. The ISIN is INE044A01036 and the face value is Rs 1.

What is the share price of Sun Pharmaceuticals Industries Ltd today? +

As of 26 October 2026, Sun Pharmaceuticals Industries Ltd trades at Rs 1,748.00, a change of -10.00 (-0.57%) on the day. Prices are live and subject to change.

What is the market capitalisation of Sun Pharmaceuticals Industries Ltd? +

As of 26 October 2026, Sun Pharmaceuticals Industries Ltd has a market cap of about Rs 418204.09 crore. This figure is live and moves with the share price.

Is Sun Pharmaceuticals Industries Ltd profitable? +

In March 2026, Sun Pharmaceuticals Industries Ltd reported a profit after tax of Rs 11,479.42 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Sun Pharmaceuticals Industries Ltd? +

: As of 26 October 2026, the PE (TTM) for Sun Pharmaceuticals Industries Ltd is 131.35 and the price-to-book ratio is 18.69. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Sun Pharmaceuticals Industries Ltd pay a dividend? +

As of 26 October 2026, the dividend yield for Sun Pharmaceuticals Industries Ltd is 0.92%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Sun Pharmaceuticals Industries Ltd? +

As of the latest disclosed pattern, promoters hold 52.68% of Sun Pharmaceuticals Industries Ltd. Public shareholding is 47.32%, including mutual funds at 13.01% and foreign institutional investors at 14.36%.

What were the latest annual financials of Sun Pharmaceuticals Industries Ltd? +

In March 2026, Sun Pharmaceuticals Industries Ltd reported net sales of Rs 58,462.04 crore, revenue growth of 11.19%, and earnings per share of Rs 47.80.